FDA Inspection 1192322 — Triad Rx, Inc

Triad Rx, Inc — FEI 3013497126

The FDA completed an inspection of Triad Rx, Inc on Dec 8, 2022 in Daphne, AL. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action). 1 citation was issued during this inspection. Product area: Veterinary.

Inspection details

Classification
Voluntary Action Indicated (VAI)
End Date
Dec 8, 2022
Fiscal Year
2023
Product Type
Veterinary
Project Area
Monitoring of Marketed Animal Drugs, Feed, and Devices
Location
Daphne, AL (United States)

Citations

IDCFRDescription
18938FDCA 501(a)(2)(A)Hazardous drugs, prevention of cross-contamination

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.